ERBB2 and breast cancer: BC can be basically divided into four different subtypes including luminal A and luminal B accounting for approximately 70% of all BCs and marked with estrogen receptor (ER)-positive3,4, human epidermal growth factor receptor 2 (HER-2) overexpression and triple negative with poorer outcomes5,6.